Caredx, inc. (CDNA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Revenue:
Total revenue

38,380

35,821

33,811

31,454

25,982

23,509

21,184

17,823

14,053

12,503

12,191

12,046

11,584

10,859

12,475

10,735

6,562

6,648

7,151

7,129

7,216

7,952

6,654

6,776

5,924

5,805

5,457

Cost of revenue

12,392

12,716

11,494

11,512

9,733

12,781

8,887

7,207

4,112

12,147

3,156

3,011

3,057

2,654

2,604

2,852

2,772

2,486

2,568

2,508

2,711

2,204

1,772

2,403

2,162

2,502

2,119

Gross profit

25,988

23,105

22,317

19,942

16,249

-

12,297

10,616

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Cost of product

-

-

-

-

-

-

-

-

-

-

-

-

2,327

-

3,355

3,056

0

-

0

0

-

-

-

-

-

-

-

Research and development

10,013

8,946

8,521

7,630

5,614

3,782

3,868

3,496

3,368

3,028

2,959

3,118

3,283

3,153

2,930

3,143

3,159

2,704

2,698

2,510

1,421

1,298

1,036

792

720

668

846

Sales and marketing

11,723

10,267

11,058

10,644

6,925

5,754

5,971

5,860

4,085

3,061

3,255

3,270

3,222

2,622

3,451

3,356

1,737

1,738

2,062

2,526

2,023

1,635

1,753

1,610

1,474

1,452

1,548

General and administrative

10,003

9,437

9,485

8,512

9,106

6,896

5,177

5,596

5,307

5,421

4,038

4,132

6,502

4,476

5,180

5,393

5,676

3,852

3,361

2,329

2,705

2,349

1,976

2,316

1,795

1,515

1,200

Goodwill impairment

-

-

-

-

-

-

-

-

-

0

0

0

1,958

13,021

0

0

0

-

-

-

-

-

-

-

-

-

-

Change in estimated fair value of contingent consideration

-

-

0

0

-

-

0

873

144

-

594

-64

-221

-34

-112

-97

-213

330

-345

142

-253

37

-1,276

0

0

0

-

Total operating expenses

31,739

28,650

29,064

26,786

21,645

9,031

15,016

15,825

19,288

-4,581

16,055

15,645

20,128

29,721

17,408

17,703

13,131

11,110

10,344

10,015

8,607

7,523

5,261

7,121

6,151

6,137

5,713

Loss from operations

-5,751

-5,545

-6,747

-6,844

-5,396

-2,415

-2,719

-5,209

-5,235

-4,287

-3,864

-3,599

-8,544

-18,862

-4,933

-6,968

-6,569

-4,462

-3,193

-2,886

-1,391

429

1,393

-345

-227

-332

-256

Other income (expense):
Interest income, net

96

306

37

300

342

-174

-408

-424

-2,695

-1,697

-1,685

-1,691

-790

-500

-568

-526

-266

-2,921

251

256

827

-389

-535

-644

-548

-497

-541

Debt extinguishment expenses

-

-

0

0

-

2,974

0

0

2,806

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in estimated fair value of common stock warrant liability

-405

333

4,346

-1,351

-3,009

1,562

-17,093

-8,768

1,321

-26,218

-8,599

1,067

4,128

1,529

1,386

-3,165

0

-

0

0

-

-

-

-

-

-

-

Other expense, net

-63

-75

-398

-172

-74

-93

-40

-42

-3

160

-317

-188

-686

1,404

-133

-274

-2,917

-136

45

-43

-54

-270

355

366

-529

-1

-5

Total other expense

-372

564

3,985

-1,223

-2,741

-1,679

-17,541

-9,234

-4,183

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-6,123

-4,981

-2,762

-8,067

-8,137

-4,094

-20,260

-14,443

-9,418

-32,501

-14,465

-4,411

-5,892

-16,429

-4,248

-10,933

-9,752

-

-3,489

-3,185

-

-

1,213

-623

-

-830

-802

Income tax benefit

-300

-259

-900

-220

-600

-329

-300

-381

-424

-872

-178

-376

-283

-717

-449

-440

0

-

0

0

-

-

0

-1,500

-

0

0

Net loss

-

-

-1,813

-7,847

-

-3,755

-19,970

-14,062

-8,994

-31,629

-14,287

-4,035

-5,609

-15,712

-3,799

-10,493

-9,752

-

-3,489

-3,185

-

-

-

-

-

-

-

Net loss attributable to noncontrolling interest

-

-

0

0

-

0

0

0

-25

42

-19

-67

-47

-229

-35

-23

0

-

0

0

-

-

-

-

-

-

-

Net loss

-5,823

-4,777

-1,813

-7,847

-7,531

-3,755

-19,970

-14,062

-8,969

-31,671

-14,268

-3,968

-5,562

-15,483

-3,764

-10,470

-9,752

-4,761

-3,489

-3,185

-2,272

-5

1,213

877

-1,304

-830

-802

Net loss per share (Note 3):
Basic (in dollars per share)

-0.14

-0.11

-0.04

-0.19

-0.18

-0.07

-0.54

-0.40

-0.30

-1.30

-0.63

-0.19

-0.26

-0.61

-0.20

-0.77

-0.81

-

-0.29

-

-

-

0.13

0.87

-

-0.82

-0.79

Diluted (in dollars per share)

-0.14

-0.11

-0.04

-0.19

-0.18

-0.07

-0.54

-0.40

-0.30

-1.30

-0.63

-0.19

-0.26

-0.55

-0.26

-0.77

-0.81

-

-0.29

-

-

-

0.12

0.13

-

-0.82

-0.79

Basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.27

-0.19

-

-

-

-1.29

-

-

Weighted-average shares used to compute net loss per share:
Basic (in shares)

42,823

42,469

42,393

42,132

41,611

40,236

37,154

35,549

29,615

28,047

22,526

21,412

21,343

21,351

19,098

13,568

11,969

-

11,890

-

-

-

9,279

1,013

-

1,011

1,011

Diluted (in shares)

42,823

42,469

42,393

42,132

41,611

40,236

37,154

35,549

29,615

28,047

22,526

21,412

21,343

20,968

19,481

13,568

11,969

-

11,890

-

-

-

11,219

6,939

-

1,011

1,011

Basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,835

11,814

-

-

-

1,011

-

-

Testing services revenue
Total revenue

31,442

29,129

28,226

25,677

21,518

18,852

16,847

13,997

10,604

8,621

8,163

8,420

7,902

7,366

8,613

7,249

6,452

6,734

7,007

7,044

7,096

6,697

6,601

6,710

5,834

5,714

5,333

Product revenue
Total revenue

4,695

5,053

4,200

4,593

4,433

4,594

4,223

3,550

3,307

3,719

3,872

3,376

3,667

3,486

3,754

3,475

0

-

0

0

-

-

-

-

-

-

-

Digital and other revenue
Revenue

2,243

1,639

1,385

1,184

31

63

114

276

142

163

156

250

15

7

108

11

110

-86

144

85

120

1,255

53

66

90

91

124

Product [Member]
Cost of testing services and product

-

-

-

-

-

-

-

-

2,272

-

2,053

2,178

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-